°Ë»ç·á |
Ç÷Àå´Ü¹é°Ë»ç |
|
Ç׿øƯÀÌÀû ¸é¿ª±Û·ÎºÒ¸°E- W14 (ºñ¸§/Åкñ¸§) |
Ç׿øƯÀÌÀû ¸é¿ª±Û·ÎºÒ¸°E- W14 (ºñ¸§/Åкñ¸§) |
35,270 |
|
|
|
|
À§Å¹ |
2023.1.1. |
°Ë»ç·á |
Ç÷Àå´Ü¹é°Ë»ç |
|
Ç׿øƯÀÌÀû ¸é¿ª±Û·ÎºÒ¸°E- IgE c73 insulin human (CAP) |
Ç׿øƯÀÌÀû ¸é¿ª±Û·ÎºÒ¸°E- IgE c73 insulin human (CAP) |
35,270 |
|
|
|
|
À§Å¹ |
2023.1.1. |
°Ë»ç·á |
»ç¶÷À¯ÀüÀÚ ºÐÀÚÀ¯Àü°Ë»ç |
|
ºñÀ¯Àü¼º À¯ÀüÀÚ°Ë»ç-±âŸ-Çü±¤µ¿¼Ò±³Àâ¹ÝÀÀ¿¡¼ ÆĶóÇÉ ºí·ÏÀ» ÀÌ¿ëÇÑ °æ¿ì |
Çü±¤µ¿¼Ò±³Àâ¹ÝÀÀ°Ë»ç FISH [FOXO-1] |
467,830 |
|
|
|
|
À§Å¹ |
2023.1.1. |
°Ë»ç·á |
»ç¶÷À¯ÀüÀÚ ºÐÀÚÀ¯Àü°Ë»ç |
|
À¯ÀüÀÚµ¹¿¬º¯ÀÌ°Ë»ç, MGMT À¯ÀüÀÚ[¸ÞÆ¿ÈƯÀÌÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ] |
À¯ÀüÀÚµ¹¿¬º¯ÀÌ°Ë»ç, MGMT À¯ÀüÀÚ[¸ÞÆ¿ÈƯÀÌÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ] |
275,000 |
|
|
|
|
À§Å¹ |
2023.1.1. |
°Ë»ç·á |
»ç¶÷À¯ÀüÀÚ ºÐÀÚÀ¯Àü°Ë»ç |
|
HLA-B51 À¯ÀüÀÚÇü °Ë»ç |
HLA-B51 À¯ÀüÀÚÇü °Ë»ç |
70,200 |
|
|
|
|
|
2023.1.1. |
°Ë»ç·á |
»ç¶÷À¯ÀüÀÚ ºÐÀÚÀ¯Àü°Ë»ç |
|
ºñÀ¯Àü¼º À¯ÀüÀÚ°Ë»ç-±âŸ-Çü±¤µ¿¼Ò±³Àâ¹ÝÀÀ,½Ç¹öµ¿¼Ò±³Àâ¹ÝÀÀ[ALK Gene] |
Çü±¤µ¿¼Ò±³Àâ¹ÝÀÀ°Ë»ç IGH/MYC/CEP8 [FISH] |
381,790 |
|
|
|
|
À§Å¹, ±Þ¿© ÀÎÁ¤±âÁØ ¿Ü ½Ç½ÃÇÑ °æ¿ì ºñ±Þ¿© |
2023.1.1. |
°Ë»ç·á |
»ç¶÷À¯ÀüÀÚ ºÐÀÚÀ¯Àü°Ë»ç |
|
ºñÀ¯Àü¼º À¯ÀüÀÚ°Ë»ç-±âŸ-Çü±¤µ¿¼Ò±³Àâ¹ÝÀÀ,½Ç¹öµ¿¼Ò±³Àâ¹ÝÀÀ[ALK Gene] |
Çü±¤µ¿¼Ò±³Àâ¹ÝÀÀ°Ë»ç Prader will/Angelman syndrome,del(15q11)[FISH] |
381,790 |
|
|
|
|
À§Å¹, ±Þ¿© ÀÎÁ¤±âÁØ ¿Ü ½Ç½ÃÇÑ °æ¿ì ºñ±Þ¿© |
2023.1.1. |
°Ë»ç·á |
»ç¶÷À¯ÀüÀÚ ºÐÀÚÀ¯Àü°Ë»ç |
|
ºñÀ¯Àü¼º À¯ÀüÀÚ°Ë»ç-±âŸ-Çü±¤µ¿¼Ò±³Àâ¹ÝÀÀ,½Ç¹öµ¿¼Ò±³Àâ¹ÝÀÀ[ALK Gene] |
Çü±¤µ¿¼Ò±³Àâ¹ÝÀÀ°Ë»ç FISH, Kallmann's syndrome |
374,660 |
|
|
|
|
À§Å¹, ±Þ¿© ÀÎÁ¤±âÁØ ¿Ü ½Ç½ÃÇÑ °æ¿ì ºñ±Þ¿© |
2023.1.1. |
°Ë»ç·á |
»ç¶÷À¯ÀüÀÚ ºÐÀÚÀ¯Àü°Ë»ç |
|
ºñÀ¯Àü¼º À¯ÀüÀÚ°Ë»ç-±âŸ-Çü±¤µ¿¼Ò±³Àâ¹ÝÀÀ,½Ç¹öµ¿¼Ò±³Àâ¹ÝÀÀ[ALK Gene] |
Çü±¤µ¿¼Ò±³Àâ¹ÝÀÀ°Ë»ç FISH, Williams Syndrome |
381,790 |
|
|
|
|
À§Å¹, ±Þ¿© ÀÎÁ¤±âÁØ ¿Ü ½Ç½ÃÇÑ °æ¿ì ºñ±Þ¿© |
2023.1.1. |
°Ë»ç·á |
»ç¶÷À¯ÀüÀÚ ºÐÀÚÀ¯Àü°Ë»ç |
|
ºñÀ¯Àü¼º À¯ÀüÀÚ°Ë»ç-±âŸ-Çü±¤µ¿¼Ò±³Àâ¹ÝÀÀ,½Ç¹öµ¿¼Ò±³Àâ¹ÝÀÀ[ALK Gene] |
Çü±¤µ¿¼Ò±³Àâ¹ÝÀÀ°Ë»ç XY[FISH] |
393,240 |
|
|
|
|
À§Å¹, ±Þ¿© ÀÎÁ¤±âÁØ ¿Ü ½Ç½ÃÇÑ °æ¿ì ºñ±Þ¿© |
2023.1.1. |